References
- Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976;590:1–64.
- Bouma B, Maas C, Hazenberg BP, Lokhorst HM, Gebbink MF. Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J Thromb Haemost 2007;5:1139–1142.
- Mumford AD, O’Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 2000;110:454–460.
- Uchiba M, Imamura T, Hata H, Tatetsu H, Yonemura Y, Ueda M, Wada Y, et al. Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells. Amyloid 2009;16:89–93.
- Adachi N, Shoji S, Yanagisawa N. Bleeding manifestations in 24 patients with familial amyloidotic polyneuropathy. Eur Neurol 1988;28:115–116.
- Kato-Motozaki Y, Ono K, Shima K, Morinaga A, Machiya T, Nozaki I, Shibata-Hamaguchi A, et al. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus. J Neurol Sci 2008;270:133–140.
- Motozaki Y, Sugiyama Y, Ishida C, Komai K, Matsubara S, Yamada M. Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study. J Neurol Sci 2007;260:236–239.
- Páramo JA, Orbe J, Beloqui O, Benito A, Colina I, Martinez-Vila E, Diez J. Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Stroke 2004;35:1085–1089.
- Ota S, Wada H, Abe Y, Yamada E, Sakaguchi A, Nishioka J, Hatada T, et al. Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis. Clin Appl Thromb Hemost 2008;14:279–285.
- Bauer KA, Goodman TL, Kass BL, Rosenberg RD. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 1985;76:826–836.
- Biasucci LM, Liuzzo G, Caligiuri G, van de Greef W, Quaranta G, Monaco C, Rebuzzi AG, et al. Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction. Am J Cardiol 1996;77:85–87.
- Brummel-Ziedins K. Blood coagulation and fibrinolysis. 12 th ed. In: Greer JP, Foerster J, Lukens JN, editors. Lippincott Williams & Wilkins Wintrobe’s clinical hematology. Philadelphia: Wolters Kluwer Health; 2009. pp 528–610.
- Collen D, Wiman B. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood 1979;53:313–324.
- Furie B, Voo L, McAdam KP, Furie BC. Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med 1981;304:827–830.